405 related articles for article (PubMed ID: 19129242)
1. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.
Yamada T; Sato K; Komachi M; Malchinkhuu E; Tobo M; Kimura T; Kuwabara A; Yanagita Y; Ikeya T; Tanahashi Y; Ogawa T; Ohwada S; Morishita Y; Ohta H; Im DS; Tamoto K; Tomura H; Okajima F
J Biol Chem; 2004 Feb; 279(8):6595-605. PubMed ID: 14660630
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
[TBL] [Abstract][Full Text] [Related]
4. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
Chen M; Towers LN; O'Connor KL
Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
Lee Z; Swaby RF; Liang Y; Yu S; Liu S; Lu KH; Bast RC; Mills GB; Fang X
Cancer Res; 2006 Mar; 66(5):2740-8. PubMed ID: 16510595
[TBL] [Abstract][Full Text] [Related]
6. Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo.
Komachi M; Sato K; Tobo M; Mogi C; Yamada T; Ohta H; Tomura H; Kimura T; Im DS; Yanagida K; Ishii S; Takeyoshi I; Okajima F
Cancer Sci; 2012 Jun; 103(6):1099-104. PubMed ID: 22348348
[TBL] [Abstract][Full Text] [Related]
7. Unmasking of LPA1 receptor-mediated migration response to lysophosphatidic acid by interleukin-1β-induced attenuation of Rho signaling pathways in rat astrocytes.
Sato K; Horiuchi Y; Jin Y; Malchinkhuu E; Komachi M; Kondo T; Okajima F
J Neurochem; 2011 Apr; 117(1):164-74. PubMed ID: 21244430
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites.
Sako A; Kitayama J; Shida D; Suzuki R; Sakai T; Ohta H; Nagawa H
J Surg Res; 2006 Jan; 130(1):94-101. PubMed ID: 16171822
[TBL] [Abstract][Full Text] [Related]
9. Dioleoyl phosphatidic acid increases intracellular Ca2+ through endogenous LPA receptors in C6 glioma and L2071 fibroblasts.
Chang YJ; Kim YL; Lee YK; Sacket SJ; Kim K; Kim HL; Han M; Bae YS; Okajima F; Im DS
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):268-76. PubMed ID: 17499746
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device.
Yamauchi A; Yamamura M; Katase N; Itadani M; Okada N; Kobiki K; Nakamura M; Yamaguchi Y; Kuribayashi F
BMC Cancer; 2017 Mar; 17(1):234. PubMed ID: 28359316
[TBL] [Abstract][Full Text] [Related]
11. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid in malignant ascites stimulates migration of human mesenchymal stem cells.
Lee MJ; Jeon ES; Lee JS; Cho M; Suh DS; Chang CL; Kim JH
J Cell Biochem; 2008 May; 104(2):499-510. PubMed ID: 18027882
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid stimulates PC-3 prostate cancer cell Matrigel invasion through activation of RhoA and NF-kappaB activity.
Hwang YS; Hodge JC; Sivapurapu N; Lindholm PF
Mol Carcinog; 2006 Jul; 45(7):518-29. PubMed ID: 16402387
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2.
Yamada T; Yano S; Ogino H; Ikuta K; Kakiuchi S; Hanibuchi M; Kanematsu T; Taniguchi T; Sekido Y; Sone S
Cancer Sci; 2008 Aug; 99(8):1603-10. PubMed ID: 18754873
[TBL] [Abstract][Full Text] [Related]
15. Dioleoyl phosphatidic acid induces morphological changes through an endogenous LPA receptor in C6 glioma cells.
Chang YJ; Kim YL; Jo JY; Kyeok K; Kim HL; Im DS
Arch Pharm Res; 2008 May; 31(5):628-33. PubMed ID: 18481020
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid signaling via LPA
Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.
Jeong KJ; Park SY; Seo JH; Lee KB; Choi WS; Han JW; Kang JK; Park CG; Kim YK; Lee HY
Exp Mol Med; 2008 Dec; 40(6):607-16. PubMed ID: 19116446
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK.
Stähle M; Veit C; Bachfischer U; Schierling K; Skripczynski B; Hall A; Gierschik P; Giehl K
J Cell Sci; 2003 Sep; 116(Pt 18):3835-46. PubMed ID: 12902401
[TBL] [Abstract][Full Text] [Related]
19. Rho-dependent, Rho kinase-independent inhibitory regulation of Rac and cell migration by LPA1 receptor in Gi-inactivated CHO cells.
Sugimoto N; Takuwa N; Yoshioka K; Takuwa Y
Exp Cell Res; 2006 Jun; 312(10):1899-908. PubMed ID: 16564043
[TBL] [Abstract][Full Text] [Related]
20. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq.
Kim J; Keys JR; Eckhart AD
Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
